Stay updated on Pembrolizumab in mHSPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in mHSPC Clinical Trial page.

Latest updates to the Pembrolizumab in mHSPC Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check12 days agoChange DetectedNew version entries appear in the Record History, reflecting updates such as recruitment status and IPD sharing metadata. No substantive study data or results are changed in these updates.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedNew revision entry v3.4.2 was added to the history and the government funding notice and Revision: v3.4.1 were removed; these changes are administrative and relate to page display and record-keeping rather than the underlying study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check41 days agoChange DetectedThe page adds a site-wide notice about potential delays due to a lapse in government funding and updates the revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.7%

- Check48 days agoChange DetectedUI improvements include a Show glossary option and color-coded highlights for additions (green) and deletions (red). The page also updates revision/version information and removes the No FEAR Act Data notice.SummaryDifference0.9%

- Check62 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the study's version history.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in mHSPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mHSPC Clinical Trial page.